In a deal worth €1.9 billion, Clariant will be taking over all of Sud-Chemie's operations including its packaging business, which develops products for the pharmaceutical, diagnostics and food supplement industries.
Clariant’s CEO Hariolf Kottman said Sud Chemie complements his firm's portfolio “with high growth businesses, less cyclicality and provides access to new market segments, strengthening our research in markets such as new materials and biotechnology.”
Part of the deal was a share swap with long standing shareholders; 8.84 shares in Clariant for one share in Sud Chemie, enabling continued participation in the company’s development as future shareholders of Clariant.
An integration process has also begun with the addition of three members of Sud Chemie’s longstanding shareholders or Supervisory Board elected to Clariant’s Board of Directors; Dr Dolf Stockhausen, Konstantin Winterstein and CEO Dr Günter von Au.